Aurora Cannabis (TSE:ACB) Price Target Lowered to C$8.00 at TD

Aurora Cannabis (TSE:ACB) had its price objective reduced by TD to C$8.00 in a research report sent to investors on Friday morning,BayStreet.CA reports. TD currently has a buy rating on the stock.

Aurora Cannabis Stock Performance

ACB opened at C$4.25 on Friday. The company has a current ratio of 5.94, a quick ratio of 2.48 and a debt-to-equity ratio of 4.66. The firm has a market capitalization of C$251.29 million, a PE ratio of -2.83 and a beta of 0.17. The firm’s 50-day moving average price is C$4.76 and its 200 day moving average price is C$5.30. Aurora Cannabis has a twelve month low of C$3.77 and a twelve month high of C$9.33.

Aurora Cannabis (TSE:ACB) last posted its earnings results on Thursday, June 11th. The company reported C($0.99) earnings per share for the quarter. The firm had revenue of C$38.01 million during the quarter. Aurora Cannabis had a negative net margin of 12.13% and a negative return on equity of 7.25%. As a group, sell-side analysts expect that Aurora Cannabis will post -0.22 EPS for the current fiscal year.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.